Ralliant Corporation Common Stock (RAL)
Healthcare › Industrial Instruments For Measurement, Display, and Control
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- Trading 162% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 12.5% — below-average profitability
Ralliant Corporation Common Stock (RAL) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NYSE , with a market capitalisation of $6.9 billion . Key value metrics: P/E ratio 35.2, P/B ratio 4.40, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ralliant Corporation Common Stock — Fundamental Analysis Summary
Ralliant Corporation Common Stock (RAL) is currently trading 162% above its Graham Number of $23.45, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 35.2x.
On financial health, RAL shows a moderate Piotroski F-Score of 6/9, and modest return on equity of 12.5% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.73.
StockPik's composite Value Score for RAL is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
RAL reports a solid gross margin of 50.4% (sector average: 40.1%) and a solid operating margin of 12.3%.
RAL shows revenue declining at 4% year-over-year, with earnings declining at 445%.
RAL pays a modest dividend yield of 0.2%.